Two Sigma Advisers’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $631K | Buy |
+48,500
| New | +$631K | ﹤0.01% | 1647 |
|
|
2021
Q3 | – | Sell |
-320,343
| Closed | -$10.8M | – | 2433 |
|
|
2021
Q2 | $10.8M | Buy |
320,343
+48,000
| +18% | +$1.62M | 0.03% | 536 |
|
|
2021
Q1 | $11.2M | Buy |
272,343
+96,700
| +55% | +$3.99M | 0.03% | 530 |
|
|
2020
Q4 | $7.62M | Buy |
175,643
+17,800
| +11% | +$772K | 0.02% | 662 |
|
|
2020
Q3 | $6.77M | Buy |
157,843
+48,600
| +44% | +$2.08M | 0.02% | 661 |
|
|
2020
Q2 | $5.11M | Buy |
109,243
+60,300
| +123% | +$2.82M | 0.02% | 784 |
|
|
2020
Q1 | $665K | Sell |
48,943
-100
| -0.2% | -$1.36K | ﹤0.01% | 1673 |
|
|
2019
Q4 | $533K | Buy |
+49,043
| New | +$533K | ﹤0.01% | 1854 |
|